The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
A major push to sharpen the future of cancer treatment is underway
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes
Subscribe To Our Newsletter & Stay Updated
